Wealthcare Advisory Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$225K Hold
3,852
– – ﹤0.01% 1013
2026
Q2
$210K Buy
+3,852
New +$188K ﹤0.01% 1026
2021
Q2
– Sell
-100
Closed -$2K – 949
2021
Q1
$2K Buy
+100
New +$2.26K ﹤0.01% 1864
2020
Q2
– Sell
-100
Closed -$2K – 646
2020
Q1
$2K Hold
100
– – ﹤0.01% 1284
2019
Q4
$2K Hold
100
– – ﹤0.01% 1255
2019
Q3
$2K Hold
100
– – ﹤0.01% 1211
2019
Q2
$2K Hold
100
– – ﹤0.01% 1182
2019
Q1
$2K Hold
100
– – ﹤0.01% 1091
2018
Q4
$2K Hold
100
– – ﹤0.01% 1075
2018
Q3
$2K Hold
100
– – ﹤0.01% 1117
2018
Q2
$2K Sell
100
-300
-75% -$6.2K ﹤0.01% 1116
2018
Q1
$9K Hold
400
– – ﹤0.01% 744
2017
Q4
$12K Hold
400
– – ﹤0.01% 628
2017
Q3
$10K Buy
+400
New +$10.6K ﹤0.01% 543

Other funds holding EXEL

Wealthcare Advisory Partners's EXEL Position: Q3 2026 in Review

Wealthcare Advisory Partners held its Exelixis (EXEL) position steady in Q3 2026 at 3,852 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Wealthcare Advisory Partners first reported a position in EXEL in Q3 2017 and has held it in 14 quarters since. 776 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Wealthcare Advisory Partners held 3,852 shares of Exelixis worth $225K as of Q3 2026.
  • Wealthcare Advisory Partners left its Exelixis share count unchanged in Q3 2026.
  • Exelixis made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q3 2026, its #1013 holding.
  • Wealthcare Advisory Partners first reported a position in Exelixis in Q3 2017 and has held it in 14 quarters since.
  • 776 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2026, filed 21 Oct 2026.